Abstract

Objective To explore the therapeutic value of endoscopic ultrasonography (EUS) com- bined with endoscopic retrograde cholangiopanereatography (ERCP) for the diagnosis and treatment of pan- ereaticobiliary diseases. Methods Clinical data were analysed retrospectively in patients who underwent both EUS and ERCP in a single anesthetic session (Group A) and separate procedure in two different ses- sions ( Group B). The following variables of both groups were evaluated : procedural time, propofol dose, ear- diopulmonary complications, endoscopic complications and diagnostic yield, and therapeutic procedures. Results Procedural time [GroupAvs. GroupB: ( 78. 56±15. 88 ) min vs. (97.78±34.56)mini andthe dose of propofol [ Group A vs. Group B : ( 314. 21 ± 223.54 ) mg vs. ( 521.23 ± 245.12 ) mg ] differed signif- icantly between both groups ( P 〈 0. 05 ). In Group A, the diagnostic rates of EUS and ERCP, cardiopulmo- nary complications rate and endoscopic complications rate were 91.4% (96/105), 81.9% (86/105), 6. 67% (7/105), 3.81% (4/105) , respectively, and these variables of group B were 94. 4% (85/90), 82.2% (74/90) , 5.56% (5/90) , 3.33% (3/90). There were no significant differences in the diagnostic yield, cardiopulmonary complications and endoscopic complications between the two groups ( P 〉 0. 05 ). Conclusion It is safe and feasible that EUS combined with ERCP is performed under anesthesia in a single session. It needs a significantly shorter procedural time and smaller dose of propofol compared with separate procedures for pancreaticobiliary diseases. Key words: Anesthesia; Cholangiopancreatography, endoscopic retrograde; Endoscopic uhraasonog- raphy; Pancreaticobiliary diseases

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call